chr14-103736036-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_015316.3(PPP1R13B):c.3198C>A(p.Asp1066Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000719 in 1,614,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015316.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PPP1R13B | NM_015316.3 | c.3198C>A | p.Asp1066Glu | missense_variant | 16/17 | ENST00000202556.14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PPP1R13B | ENST00000202556.14 | c.3198C>A | p.Asp1066Glu | missense_variant | 16/17 | 1 | NM_015316.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000962 AC: 24AN: 249436Hom.: 0 AF XY: 0.0000665 AC XY: 9AN XY: 135374
GnomAD4 exome AF: 0.0000739 AC: 108AN: 1461868Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 49AN XY: 727238
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152176Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.3198C>A (p.D1066E) alteration is located in exon 16 (coding exon 16) of the PPP1R13B gene. This alteration results from a C to A substitution at nucleotide position 3198, causing the aspartic acid (D) at amino acid position 1066 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at